Join Now
Trastuzumab is a monoclonal antibody. It is used to treat breast cancer that has spread to other parts of the body. Trastuzumab may prevent the growth of some breast tumors that produce extra amounts of a certain substance known as the HER2 protein. Trastuzumab should be used only in certain patients whose breast tu... continue
More Information About Herceptin
Treatment Success Rate
| Top 5 Communities | ||
| Condition | Members | Success |
| Breast Cancer | 25 |
88% |
| Depression - Teen | 1 |
100% |
Overall, 88% (26
Members)
find Herceptin helpful
Herceptin Reviews
Working / Worked
She is still in treatment
Working / Worked
i am going thrrough the herceptin now.
Working / Worked
Working / Worked
An easy drug to tolerate. No side effects. Expensive; good thing I have insurance.
Working / Worked
I have had no side effects from the Herceptin at all.
Working / Worked
Worked for 2 1/2 years...
Working / Worked
Working / Worked
No major problems with this one. One thing for sure was weight gain.
Working / Worked
worked
Working / Worked
My miracle drug!!!I am almost 2 years cancer free however combined with AC left me with heart damage.
Showing 1 - 10 of 34 Reviews
Discussions
-
Herceptin
I have been going through herceptin for a year and i am all most done with it.I have had radiation and i am done with that. I am going to have Recon... [More] -
Herceptin
I have been taking Herceptin since January. I understand I will be taking it every three weeks the rest of this year. How many of you have taken it,... [More] -
HERCEPTIN
Herceptin can be an effective treatment both before and after surgery for people with HER2-positive breast cancer. It has also been shown to reduce th... [More] -
HERCEPTIN
Based on a couple of websites I visited HER2/neu is a gene. Some breast cancers are caused by having too many of them. Herceptin is a kind of chemo ... [More] -
HERCEPTIN
I HAVE LIVER CANCER. CALLED HER2NEU AND THEY WANT TO PUT ME ON HERCEPTIN. I HAD COLON CANCER AND THEY REMOVED ALL OF MY RIGHT COLON ALONG WITH A PIECE... [More]
